A recombinant cytotoxic chimera based on mammalian deoxyribonuclease-I

International Journal of Cancer

Volumn 86, Issue 4, 2000, Pages 561-569

  Linardou, Helena ^a   Epenetos, Agamemnon A ^a,c   Deonarain, Mahendra P ^b  

^a Department of Clinical Oncology   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DOUBLE STRANDED DNA;

ANTIGEN BINDING; ARTICLE; CHIMERA; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT DNA TECHNOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; DEOXYRIBONUCLEASE I; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTOXINS; RECOMBINANT FUSION PROTEINS;

EID: 0034021722     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000515)86:4<561::AID-IJC19>3.0.CO;2-5     Document Type: Article

References (33)

1. BONGARTZ, J.-P., AUBERTIN, A.-M., MILHAUD, P.G. and LEBLEU, B., Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucl. Acids Res., 22, 4681-4688 (1994).
2. DEONARAIN, M.P. and EPENETOS, A.A., Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins. Brit. J. Cancer, 77, 537-546 (1998).
3. DEONARAIN, M.P., ROWLINSON-BUSZA, G., GEORGE, A.J.T. and EPENETOS, A.A., Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targeting Protein Engin., 10, 89-98 (1997).
4. ENARI, M., SAKAHIRA, H., YOKOYAMA, H., OKAWA, K., IWAMATSU, A. and NAGATA, S., A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.), 391, 43-50 (1998).
5. EPENETOS, A.A., CARR, D., JOHNSON, P.M., BODMER, W.F. and LAVENDER, J.P., Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase. Brit. J. Radiol., 59, 117-125 (1986).
6. EPENETOS, A.A., TRAVERS, P., GATTER, K.C., OLIVER, R.D., MASON, D.Y. and BODMER, W.F., Immuno-histological study of testicular germ cell tumours, other neoplasms and normal tissues using two different monoclonal antibodies against placental alkaline phosphatase. Brit. J. Cancer, 49, 11-15 (1984).
7. GHETIE, M.-A. and VITETTA, E.S., Recent developments in immunotoxin therapy. Curr. Opin. Immunol., 6, 707-714 (1994).
8. JOHNSON, A.J., GOGER, P.R. and TILLETT, W.S., The intravenous injection of bovine crystalline pancreatic deoxyribonuclease into patients. J. clin. Invest., 33, 1670 (1954).
9. JONES, S.J., WORRALL, A.F. and CONNOLLY, B.A., Site directed mutagenesis of the catalytic residues of bovine pancreatic deoxyribonuclease-I. J. mol. Biol., 264, 1154-1163 (1996).
10. KAYALAR, C. ÖRD, T., TESTA, M.P., ZHONG, L..-T. and BREDESEN, D.E., Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase-I inhibition. Proc. nat. Acad. Sci. (Wash.), 93, 2234-2238 (1996).
11. KIHARA, A. and PASTAN, I., Small chimeric toxins containing only transforming growth factor α and domain III of pseudomonas exotoxin with good anti-tumor activity in mice. Cancer Res., 54, 5154-5159 (1994).
12. KUNITZ, M., Crystalline deoxyribonuclease I: isolation and general properties. Spectrophotometric method for the measurement of deoxyribonuclease activity. J. gen. Physiol., 39, 349-362 (1950).
13. LACKS, S.A., Deoxyribonuclease-I in mammalian tissue. J. biol. Chem., 256, 2644-2648 (1981).
14. LANFORD, R.E., KANDA, P. and KENNEDY, R.C., Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell 46, 575-582 (1986).
15. LASKE, D.W., YOULE, R.J. and OLDFIELD, E.H., Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nature Med., 3, 1362-1368 (1997).
16. LAZARIDES, E. and LINDBERG, U., Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc. nat. Acad. Sci. (Wash.), 71, 4742-4746 (1974).
17. LLOYD, T.W., Clinical uses of systemic deoxyribonuclease. Geront. Clin., 10, 116-127 (1968).
18. MAKIYA, R. and STIGBRAND, T., Placental alkaline phosphatase has a site for the human immunoglobulin-G Fc portion. Europ. J. Biochem., 205, 341-345 (1992).
19. NEWTON, D.L., XUE, Y., OLSON, K.A., FETT, J.W. and RYBAK, S.M., Angiogenin single-chain immunofusions: influences of peptide linkers and spacers between fusion protein domains. Biochemistry, 35, 545-553 (1996).
20. OEFNER, C. and SUCK, D., Crystallographic refinement and structure of DNase-I at 2Å resolution. J. mol. Biol., 192, 605-632 (1986).
21. PAN, C.Q., DODGES, T.H., BAKER, D.L., PRIONCE, W.S., SINICROPI, D.V. and LAZARUS, R.A., Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus. J. biol. Chem., 273, 18374-18381 (1998).
22. PAN, C.Q. and LAZARUS, R.A., Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism. Biochemistry, 36, 6624-6632 (1997).
23. POLZAR, B., PEITSCH, M.C., LOOS, R., TSCHOPP, J. and MANNHERZ, H.G., Overexpression of deoxyribonuclease-I (DNase-I) transfected into COS cells: its distribution during apoptotic cell death. Europ. J. cell. Biol., 62, 397-405 (1993).
24. 2+ in the activity of bovine pancreatic deoxyribonuclease J. biol. Chem., 250, 1981-1986 (1975).
25. PRICE, P.A., STEIN, W.H. and MOORE, S., Effect of divalent cations on the reduction and reformation of disulphide bonds of deoxyribonuclease. J. biol. Chem., 244, 929-932 (1969).
26. REITER, Y. and PASTAN, I., Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis. Trends Biotech., 16, 513-520 (1998).
27. SHAK, S., CAPON, D.J., HELLMISS, R., MARSTERS, S.A. and BAKER, C.L., Recombinant human DNase-I reduces the viscosity of cystic fibrosis sputum. Proc. nat. Acad. Sci. (Wash.), 87, 9188-9192 (1990).
28. SPOONER, R.A., MURRAY, S., ROWLINSON-BUSZA, G., DEONARAIN, M.P., CHU, A. and EPENETOS, A.A., Genetically engineering antibodies for diagnostic pathology. Hum. Pathol., 25, 606-614 (1994).
29. SUGIHARA, S., YAMAMOTO, T., TANAKA, H., KAMBARA, T., HIRAOKA, T. and MIYAUCHI, Y., Deoxyribonuclease treatment prevents blood-borne liver metastases of subcutaneously transplanted tumour cells in mice. Brit. J. Cancer, 67, 66-70 (1993).
30. TRAVERS, P. and BODMER, W., Preparation and characterisation of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast associated determinants. Int. J. Cancer, 33, 633-641 (1984).
31. ULMER, J.S., HERZKA, A., TOY, K.J., BAKER, D.L., DODGE, A.H., SINICROPI, D., SHAK, S. and LAZARUS, R.A., Engineering actin-resistant human DNase-I for treatment of cystic fibrosis. Proc. nat. Acad. Sci. (Wash.), 93, 8225-8229 (1996).
32. WOLF, E., BRUKNER, I. and SUCK, D., Mutational analyses of DNase-I-DNA interaction: design, expression and characterisation of a DNase-I loop insertion mutant with altered sequence specificity. Prot. Engin., 8, 283-291 (1995).
33. WORRALL, A.F. and CONNOLLY, B.A., The chemical synthesis of the gene coding for bovine pancreatic DNase-I and its cloning and expression in Escherichia coli. J. biol. Chem., 265, 21889-21895 (1990).